Physician profile
Luann Aquino
NPI 1659399566
$1,401.55
in general payments reported to CMS, 2019-2025
20 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.77 · 2021: $102 · 2022: $168 · 2023: $14.83 · 2024: $24.61 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $352.37 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $195.71 | 2021-2025 | |
| Lundbeck LLC | $163.56 | 2024-2025 | Vyepti |
| Lilly USA, LLC | $98.38 | 2025 | Kisunla, Mounjaro, Zepbound |
| Allergan, INC. | $96.75 | 2022 | |
| Astellas Pharma US INC | $65.00 | 2019 | |
| Pfizer INC. | $64.70 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $51.65 | 2025 | Airsupra |
| Boston Scientific Corporation | $49.43 | 2025 | Watchman Flx |
| Eisai INC. | $34.90 | 2025 | |
| Exact Sciences Corporation | $33.77 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Sk Life Science, INC. | $33.34 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $31.68 | 2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $26.79 | 2022-2023 | Livalo, Seglentis |
| Axsome Therapeutics, INC. | $26.43 | 2025 | Symbravo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $18.09 | 2025 | Austedo Xr |
| Bayer Healthcare Pharmaceuticals INC. | $17.86 | 2022 | |
| Biogen, INC. | $14.09 | 2025 | Leqembi |
| Amgen INC. | $13.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luann Aquino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.